As a Clinical Project Manager at Compass Pathways, I lead Phase I–III clinical trials in the U.S. and U.K., advancing psychedelic research through strategic oversight and operational excellence. I manage all trial activities from study start-up to closeout, ensuring inspection readiness, regulatory compliance, and delivery on timelines and budgets.

My responsibilities include leading cross-functional teams, managing CROs and vendors, driving site activation, overseeing recruitment and monitoring, and resolving operational challenges in real time. I ensure GCP adherence and maintain quality across all phases, contributing to the successful execution of complex, high-impact studies that advance innovative mental health therapies.

Led global Phase II and III oncology trials across the U.S., U.K., Spain, Italy, China, South Korea, and Japan—providing strategic oversight to CROs and clinical site teams from study start-up through closeout. Directed feasibility activities and ensured alignment with clinical objectives, regulatory requirements, and patient safety standards in my dual role as Regulatory and Safety Manager.

Managed investigational sites to ensure protocol compliance and operational continuity across regions. Spearheaded the development of Clinical Department SOPs, study plans, and critical documents including protocols and informed consent forms. Maintained strict adherence to the Clinical Monitoring Plan, conducted site visits, finalized monitoring reports, and addressed protocol deviations promptly.

Trained CRAs and PMs on protocol execution and operational SOPs, and served as a co-monitor when needed—ensuring high-quality trial conduct and inspection-ready documentation across all participating countries.

Supported cross-functional study teams by assisting with feasibility assessments and coordinating study supply distribution to ensure site readiness. Maintained Trial Master File (TMF) integrity, generated essential study documentation, and collaborated closely with Medpace and Sponsor teams to support operational success.

As a Clinical Research Associate (CRA), I conducted Phase I–III clinical trials, including medical device studies, overseeing pre-study, initiation, monitoring, and close-out visits in compliance with SOPs and ICH-GCP. I managed site operations, scheduled and executed monitoring visits, and ensured data accuracy through study database oversight. My responsibilities also included subject safety monitoring, adverse event reporting, and reconciliation of Investigator Site Files (ISF) to ensure full alignment with the TMF, supporting audit readiness and regulatory compliance.

Taught undergraduate and postgraduate courses in Molecular Biology, Biochemistry, and Recombinant DNA Technology. Assessed student performance, provided academic guidance, and submitted detailed reports on academic progress. Delivered personalized support to students facing academic challenges, with regular follow-ups to promote improved comprehension and academic success.

I employed innovative teaching techniques to enhance student learning outcomes, administered exams, and facilitated remediation to help students achieve their educational goals. Additionally, I played a pivotal role in supporting weekly lab sessions in Genetic Engineering, Biochemistry, Molecular Biology, and Recombinant DNA technology, fostering student engagement, comprehension, and the attainment of learning objectives.